Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A new accountable care agreement between Aetna and Bon Secours Health System will support 57,000 Medicare beneficiaries in Kentucky, New York, South Carolina and Virginia.
A new report offers four clinical scenarios that could result in use of an emergency department information system contributing to medical errors as well as recommendations to make the systems safer to use.
An updated problem list is part of the Meaningful Use objectives but it can be tricky to maintain—what goes on the list, who updates the list and what are best practices for the best use of problem lists?
The journey to accountable care is fraught with challenges and opportunities. Newly formed ACOs in California, Maine and Maryland are finding that an ability to capture beneficiary data so they can target the highest risk patients is key to success.
Healthcare innovation centers are popping up all over—even Medicare has established its own innovation center with an impressive budget. How are these centers helping get innovations from idea into practice and how might they evolve in coming years?
One of the most common questions asked these days is “What is healthcare innovation?” Like the story of the blind men touching different sides of an elephant and each describing something separate, you will hear a wide variety of answers to this question based on whom you ask.
Despite the sunny days and warm breezes, it feels like the calm before a storm.We’re edging up to the one-year mark until there will be just one year left until the October 1, 2014 ICD-10 implementation deadline. Can you hear the clock ticking?
The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.
